-
Session to address the economic and health value of obesity treatment
Panelists, including Tim Dall, MS, will help make business and social cases for investing in evidence-based treatment for obesity, such as lower healthcare costs, improved quality of life, and reduced mortality.
-
Diabetes Journal symposium to explore non-classical complications of diabetes
Norbert Stefan, MD, PhD, and three other panelists will present the latest findings on how complications such as metabolic dysfunction-associated steatotic liver disease (MASLD), infections, cancer, and diastolic dysfunction are impacting individuals living with diabetes.
-
Authors to explain updates to new consensus statement on managing hyperglycemia in type 2 diabetes
Jennifer Green, MD, and others involved in updating the guidance from the ADA and the European Association for the Study of Diabetes, will discuss the rationale behind the shifting emphasis on assessing and changing behaviors and medications to improve outcomes over a person’s lifespan.
-
Panelists to outline impact of youth substance use on diabetes care
Elissa Weitzman, ScD, MSc, will be part of a trio of presenters in an Ask the Experts session focused on how to integrate conversations about the use of tobacco, alcohol, cannabis, pain medications, and other substances into clinical care for young people living with diabetes.
-
Panel to review the impact of disordered eating in diabetes and obesity
Nicole Patience, MS, RDN, LDN, CEDS-C, CDCES, and other experts will explain how eating disorders and imbalanced eating can affect people living with diabetes or obesity and how to help them achieve sustainable wellness.
-
Symposium to examine AI’s current and near-future impact on diabetes tech
Boris Kovatchev, PhD, and other panelists will share recent developments in the application of artificial intelligence in automated insulin delivery, clinical decision-making, nutrition estimation, diabetes coaching, and more.
-
Innovation Challenge to pitch groundbreaking projects for diabetes
The Innovation Challenge returns with live presentations on Saturday from five emerging companies developing game-changing solutions to real-world problems affecting people living with diabetes, their family members, or caregivers.
-
Obesity Year in Review to give an overview of major advances and discoveries
Presentations in this opening-day symposium will include a review of recent literature on the clinical application of glucagon-like peptide-1 (GLP-1)-based drugs by Julio E. Ayala, PhD, who will also identify knowledge gaps that can guide future clinical trials.
-
Presenter Profile: Effects of Sugar and Non-Nutritive Sweeteners on Brain and Metabolic Health
Katie Page, MD, previews a presentation at the 2026 Scientific Sessions. Attendees in New Orleans can watch the session in-person Sunday, June 7, at 8:00 a.m. CT.
-
Presenter Profile: Recharging Renal Energy: Novel Therapies for Mitochondrial Dysfunction in Diabetic Kidney Disease
Prabhleen (Sheena) Singh, MD, previews a presentation at the 2026 Scientific Sessions. Attendees in New Orleans can watch the session in-person Sunday, June 7, at 4:30 p.m. CT.